The latest price target for Elanco Animal Health (NYSE:ELAN) was reported by Piper Sandler on July 1, 2024. The analyst firm set a price target for $16.00 expecting ELAN to rise to within 12 months (a possible 9.81% upside). 16 analyst firms have reported ratings in the last year.

The latest analyst rating for Elanco Animal Health (NYSE:ELAN) was provided by Piper Sandler, and Elanco Animal Health maintained their neutral rating.

The last upgrade for Elanco Animal Health Inc happened on January 5, 2024 when Stifel raised their price target to $20. Stifel previously had a hold for Elanco Animal Health Inc.

The last downgrade for Elanco Animal Health Inc happened on August 18, 2022 when Morgan Stanley changed their price target from $37 to $22 for Elanco Animal Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elanco Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elanco Animal Health was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.

While ratings are subjective and will change, the latest Elanco Animal Health (ELAN) rating was a maintained with a price target of $19.00 to $16.00. The current price Elanco Animal Health (ELAN) is trading at is $14.57, which is out of the analyst’s predicted range.